LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Trials Apogee Therapeutics has launched a first-in-human clinical trial for APG990, a promising treatment for atopic dermatitis, signaling potential partnerships with healthcare providers and pharmaceutical companies interested in innovative therapies.

Strategic Investments Recent investments from Jennison Associates LLC, China Universal Asset Management Co. Ltd., and Adage Capital Partners GP L.L.C. illustrate confidence in Apogee Therapeutics' growth trajectory, presenting an opportunity for strategic collaborations or joint ventures.

Experienced Leadership With the appointment of Jeff S. Hartness as Chief Commercial Officer and Lisa Bollinger to its board of directors, Apogee Therapeutics demonstrates a strong leadership team, which can be leveraged to expand market reach through established industry connections.

Public Listing Having gone public in May 2023 and raised $345 million in IPO funds, Apogee Therapeutics is well-positioned to engage with investors, potentially attracting interest from institutional funds and high net-worth individuals seeking biotechnology opportunities.

Competitive Landscape In a market with similar biotechnology companies like Casma Therapeutics, Boundless Bio, and Generation Bio, Apogee Therapeutics' revenue range and focus on immunological therapies present opportunities for differentiation and collaboration within the competitive landscape.

Similar companies to Apogee Therapeutics

Apogee Therapeutics Tech Stack

Apogee Therapeutics uses 8 technology products and services including SAS, Typekit, DocuSign, and more. Explore Apogee Therapeutics's tech stack below.

  • SAS
    Business Intelligence
  • Typekit
    Font Scripts
  • DocuSign
    Miscellaneous
  • Gatsby
    Page Builders
  • Calibre
    Performance
  • Microsoft Azure
    Platform As A Service
  • Smartsheet
    Project Management
  • Adobe Creative Suite
    Visualisation Software

Apogee Therapeutics's Email Address Formats

Apogee Therapeutics uses at least 1 format(s):
Apogee Therapeutics Email FormatsExamplePercentage
First.Last@apogeetherapeutics.comJohn.Doe@apogeetherapeutics.com
50%
First.Last@apogeetherapeutics.comJohn.Doe@apogeetherapeutics.com
50%

Frequently Asked Questions

Where is Apogee Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Apogee Therapeutics's main headquarters is located at Fully Remote, US US. The company has employees across 2 continents, including North AmericaEurope.

What is Apogee Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Apogee Therapeutics is a publicly traded company; the company's stock symbol is APGE.

What is Apogee Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Apogee Therapeutics's official website is apogeetherapeutics.com and has social profiles on LinkedIn.

How much revenue does Apogee Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Apogee Therapeutics's annual revenue reached $15M.

What is Apogee Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Apogee Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Apogee Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Apogee Therapeutics has approximately 147 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer At Apogee Therapeutics: M. H.Chief Medical Officer: C. D.Chief Financial Officer: J. P. H.. Explore Apogee Therapeutics's employee directory with LeadIQ.

What industry does Apogee Therapeutics belong to?

Minus sign iconPlus sign icon
Apogee Therapeutics operates in the Biotechnology Research industry.

What technology does Apogee Therapeutics use?

Minus sign iconPlus sign icon
Apogee Therapeutics's tech stack includes SASTypekitDocuSignGatsbyCalibreMicrosoft AzureSmartsheetAdobe Creative Suite.

What is Apogee Therapeutics's email format?

Minus sign iconPlus sign icon
Apogee Therapeutics's email format typically follows the pattern of . Find more Apogee Therapeutics email formats with LeadIQ.

How much funding has Apogee Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Apogee Therapeutics has raised $483M in funding. The last funding round occurred on Mar 07, 2024 for $483M.

When was Apogee Therapeutics founded?

Minus sign iconPlus sign icon
Apogee Therapeutics was founded in 2022.
Apogee Therapeutics

Apogee Therapeutics

Biotechnology ResearchUS, United States51-200 Employees

Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders. 

Section iconCompany Overview

Headquarters
Fully Remote, US US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
APGE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2022
Employees
51-200

Section iconFunding & Financials

  • $483M

    Apogee Therapeutics has raised a total of $483M of funding over 3 rounds. Their latest funding round was raised on Mar 07, 2024 in the amount of $483M.

  • $10M$50M

    Apogee Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $483M

    Apogee Therapeutics has raised a total of $483M of funding over 3 rounds. Their latest funding round was raised on Mar 07, 2024 in the amount of $483M.

  • $10M$50M

    Apogee Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.